Dr. Arvid Lindau and discovery of von Hippel-Lindau disease.
Arvid Lindau, MD, PhD, consolidated the disparate array of benign and malignant visceral and nervous system lesions into the neoplastic syndrome known as von Hippel-Lindau (VHL) disease. Based on this pioneering work, Dr. Lindau was awarded both a Rockefeller fellowship to work in Dr. Harvey Cushing's laboratory in Boston, Massachusetts, and the Lennmalm Prize. While working in Dr. Cushing's laboratory, Dr. Lindau continued his study of CNS hemangioblastomas. His work with Dr. Cushing led to their lifelong friendship and scientific collaboration. In this paper the authors describe Arvid Lindau's pioneering work in nervous system tumor pathology, his relationship to Dr. Cushing, and his role in advancing neurological surgery and research in Europe.
Department of Neurological Surgery, The Ohio State University Wexner Medical Center, Columbus, Ohio;|Surgical Neurology Branch, National Institute of Neurological Disorders and Stroke, National Institutes of Health, Bethesda, Maryland; and.
Kristin
K
Huntoon
Department of Neurological Surgery, The Ohio State University Wexner Medical Center, Columbus, Ohio;|Department of Neurological Surgery, University of Virginia Health Sciences Center, Charlottesville, Virginia.
Edward H
EH
Oldfield
Department of Neurological Surgery, The Ohio State University Wexner Medical Center, Columbus, Ohio;|Surgical Neurology Branch, National Institute of Neurological Disorders and Stroke, National Institutes of Health, Bethesda, Maryland; and.
Russell R
RR
Lonser
D049674:History, 21st Century; D013548:Sweden; D006623:von Hippel-Lindau Disease / Q000266:history*
Arvid Lindau; Harvey Cushing; VHL = von Hippel-Lindau; hemangioblastoma; history; von Hippel-Lindau disease